ExodusPoint Capital Management LP bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 169,412 shares of the medical research company's stock, valued at approximately $22,759,000. ExodusPoint Capital Management LP owned 0.06% of Agilent Technologies at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new stake in Agilent Technologies during the 4th quarter worth $456,963,000. Madison Investment Advisors LLC purchased a new position in Agilent Technologies during the 4th quarter worth approximately $94,051,000. Raymond James Financial Inc. acquired a new position in Agilent Technologies during the fourth quarter worth approximately $48,172,000. Worldquant Millennium Advisors LLC purchased a new stake in Agilent Technologies in the third quarter valued at approximately $49,449,000. Finally, Van ECK Associates Corp grew its position in shares of Agilent Technologies by 8.7% during the fourth quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company's stock worth $434,625,000 after acquiring an additional 258,358 shares during the last quarter.
Wall Street Analyst Weigh In
Several research analysts have issued reports on the stock. Robert W. Baird lowered their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a research report on Thursday, February 27th. Citigroup boosted their price target on Agilent Technologies to $165.00 and gave the company a "buy" rating in a research report on Thursday, December 19th. Bank of America decreased their price objective on Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating for the company in a research report on Friday, December 13th. Wells Fargo & Company lowered their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating on the stock in a report on Monday, December 9th. Finally, StockNews.com upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Tuesday, December 24th. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $150.83.
View Our Latest Stock Report on A
Agilent Technologies Stock Up 0.4 %
Shares of Agilent Technologies stock traded up $0.40 during trading on Tuesday, reaching $103.99. The company had a trading volume of 1,220,853 shares, compared to its average volume of 1,803,128. Agilent Technologies, Inc. has a fifty-two week low of $98.51 and a fifty-two week high of $155.35. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The company has a market cap of $29.65 billion, a price-to-earnings ratio of 23.91, a price-to-earnings-growth ratio of 2.89 and a beta of 1.19. The firm's fifty day moving average is $129.40 and its 200-day moving average is $135.44.
Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The company had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.57 EPS for the current year.
Agilent Technologies Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.95%. Agilent Technologies's dividend payout ratio is presently 22.76%.
Insider Buying and Selling
In related news, CEO Padraig Mcdonnell sold 1,911 shares of the firm's stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares of the company's stock, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the sale, the director now owns 35,737 shares of the company's stock, valued at $4,161,931.02. The trade was a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,638 shares of company stock valued at $731,229 over the last quarter.
Agilent Technologies Profile
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
